Form 13-F position report

ORTHOFIX MED INC

Reported by GABELLI FUNDS LLC

OFIX CUSIP 68752M108 Manager CIK 0001081407

Reported 234,303 shares, down 22,820 (8.9%) from the prior quarter.

Reported value 19.6%; share count -8.9% vs. the prior quarter.

Reduced
% of reported 13F value 0.02% This manager · Q3 2025
Shares 234,303 Quarter-end amount reported
Reported value $3,430,196 Fair value at quarter end
Consecutive quarters held 29 Through Q3 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 9153000
2021-12-31 7465000
2022-03-31 7352000
2022-06-30 5293000
2022-09-30 4297000
2022-12-31 2853670
2023-03-31 2328250
2023-06-30 2510340
2023-09-30 1736100
2023-12-31 1880460
2024-03-31 2119920
2024-06-30 2088450
2024-09-30 2444530
2024-12-31 2627730
2025-03-31 2454655
2025-06-30 2866921
2025-09-30 3430196
2025-12-31 3567193
2026-03-31 2568626
2026-06-30 999002

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for ORTHOFIX MED INC held by GABELLI FUNDS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 109,300 -114,643 (-51.2%) < 0.01% $999,002 2026-08-12
Q1 2026 Reduced 223,943 -11,360 (-4.8%) 0.02% $2,568,626 2026-05-14
Q4 2025 Added 235,303 +1,000 (0.4%) 0.02% $3,567,193 2026-02-05
Q3 2025 Reduced 234,303 -22,820 (-8.9%) 0.02% $3,430,196 2025-11-12
Q2 2025 Added 257,123 +106,623 (70.8%) 0.02% $2,866,921 2025-08-13
Q1 2025 Unchanged 150,500 0 (0.0%) 0.02% $2,454,655 2025-05-14
Q4 2024 Reduced 150,500 -6,000 (-3.8%) 0.02% $2,627,730 2025-02-13
Q3 2024 Reduced 156,500 -1,000 (-0.6%) 0.02% $2,444,530 2024-11-13
Q2 2024 Added 157,500 +11,500 (7.9%) 0.02% $2,088,450 2024-08-13
Q1 2024 Added 146,000 +6,500 (4.7%) 0.02% $2,119,920 2024-05-14
Q4 2023 Added 139,500 +4,500 (3.3%) 0.01% $1,880,460 2024-02-13
Q3 2023 Reduced 135,000 -4,000 (-2.9%) 0.01% $1,736,100 2023-11-08
Q2 2023 Unchanged 139,000 0 (0.0%) 0.02% $2,510,340 2023-08-10
Q1 2023 Unchanged 139,000 0 (0.0%) 0.02% $2,328,250 2023-05-12
Q4 2022 Reduced 139,000 -85,837 (-38.2%) 0.02% $2,853,670 2023-02-13
Q3 2022 Unchanged 224,837 0 (0.0%) 0.04% $4,297,000 2022-11-10
Q2 2022 Unchanged 224,837 0 (0.0%) 0.04% $5,293,000 2022-08-12
Q1 2022 Reduced 224,837 -15,281 (-6.4%) 0.05% $7,352,000 2022-05-13
Q4 2021 Unchanged 240,118 0 (0.0%) 0.05% $7,465,000 2022-02-11
Q3 2021 Unchanged 240,118 0 (0.0%) 0.06% $9,153,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

183 managers reported ORTHOFIX MED INC for Q3 2025.

Managers reporting ORTHOFIX MED INC in Q3 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Engine Capital Management LP Added 4,252,921 +1,250 7.39% $62,262,763 8 qtrs
Rubric Capital Management LP Unchanged 3,721,715 0 0.61% $54,485,908 11 qtrs
PARADIGM CAPITAL MANAGEMENT INC NY Added 3,344,500 +3,900 2.12% $48,963,480 11 qtrs
BlackRock Inc Reduced 3,137,570 -73,981 < 0.01% $45,934,026 5 qtrs
Juniper Investment Company LLC Added 2,847,055 +377,729 15.94% $41,680,885 6 qtrs
VANGUARD GROUP INC Reduced 2,282,670 -59,584 < 0.01% $33,418,289 29 qtrs
ARMISTICE CAPITAL LLC Reduced 2,236,000 -742,000 0.49% $32,735,040 12 qtrs
MILLENNIUM MANAGEMENT LLC Added 1,475,718 +684,850 < 0.01% $21,604,512 8 qtrs
DIMENSIONAL FUND ADVISORS LP Added 1,142,545 +68,596 < 0.01% $16,725,596 29 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 941,320 +11,068 < 0.01% $13,783,917 30 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2025
Filed
November 12, 2025
Filing type
13F-HR
Position type
EQUITY

Voting authority reported

Sole
234,303
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.